Advertisement
Advertisement

BAX

BAX logo

Baxter International Inc.

30.61
USD
-0.75
-2.39%
Jun 13, 15:59 UTC -4
Closed
exchange

After-Market

31.13

+0.52
+1.69%

Baxter International Inc. Profile

About

Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.

Info & Links

CEO

Brent Shafer

Headquarters

One Baxter Parkway
Deerfield, IL 60015, UNITED STATES

Industry

Medical Products

Sector

Medical

Website

www.baxter.com

Auditor

PricewaterhouseCoopers LLP

Share holders

18,094

Employees

38,000

Baxter International Inc. Statistics

Valuation Measures

Market Capitalization2

15.97B

Enterprise Value

23.75B

Enterprise Value/EBITDA(ttm)

16.91

Price to Earnings Ratio(ttm)

12.34

Price to Sales(ttm)

1.33

Price to Book(mrq)

2.15

Price to Cash(ytd)

6.38

Profitability

Gross Margin(ttm)

35.70%

Operating Margin(ttm)

10.32%

Profit Margin(ttm)

-7.39%

Return on Equity(ttm)

16.67%

Return on Invested Capital(ttm)

-1.46%

Return on Assets(ttm)

4.93%

Income Statement

Revenue(ttm)

10.77B

Revenue Per Share(ttm)

20.99

Gross Profit(ttm)

3.88B

EBITDA(ttm)3

1.41B

Net Income Available to Common(ttm)

-560.00M

Diluted EPS(ttm)

-1.28

Share Statistics

Beta (5Y Monthly)

0.61

52-Week Change

-9.39%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

513.17M

Dividend Yield

2.03%

Float4

509.52M

% Held by Insiders

0.21%

% Held by Institutions

90.19%

Balance Sheet

Total Cash(mrq)

2.29B

Total Cash Per Share(mrq)

4.47

Total Debt(mrq)

10.07B

Total Debt/Equity(mrq)

142.81%

Current Ratio(mrq)

2.02%

Quick Ratio(mrq)

1.09%

Book Value Per Share(mrq)

13.75

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.38

Free Cash Flow(ytd)

-315.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement